Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein
Iva Sorić Hosman, Andrea Cvitković Roić, Ivana Vuković Brinar, Tonko Gulin, Marijana Ćorić, Dunja Rogić, Ana Lončar Vrančić, Lovro Lamot · 2024
Read Cathelicidin in Urinary Tract Diseases: Diagnostic, Prognostic and Therapeutic Potential of an Evolutionary Conserved Antimicrobial Protein by Iva Sorić Hosman, Andrea Cvitković Roić, Ivana Vuković Brinar, Tonko Gulin, Marijana Ćorić, Dunja Rogić, Ana Lončar Vrančić, Lovro Lamot (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11728125.txt.
Description
Iva Soric Hosman and co-authors review, in a 2024 paper, a germ-fighting protein that may help spot and treat urinary tract disease. Such infections are among the most common in care, and germs that resist drugs make them harder to treat. The protein, cathelicidin, is an old defense kept in humans by a single gene. Skin cells that line the urinary tract make it fast on contact with a germ, before white blood cells arrive.
On top of killing germs, the protein calls in immune cells and spurs signal release. That early role makes it a strong candidate mark for a fast diagnosis. Two decades of studies back its use to spot infection, the team notes. Low levels after an infection clears may also flag who will fall ill again. The review weighs its worth as a test and as a drug lead.
Catalog record
| CREATOR | Iva Sorić Hosman, Andrea Cvitković Roić, Ivana Vuković Brinar, Tonko Gulin, Marijana Ćorić, Dunja Rogić, Ana Lončar Vrančić, Lovro Lamot |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 35 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |